Literature DB >> 19412423

Polymorphisms of Metabolizing Enzymes and Susceptibility to Ethmoid Intestinal-type Adenocarcinoma in Professionally Exposed Patients.

Elisa Pastore1, Federica Perrone, Marta Orsenigo, Luigi Mariani, Clara Millefanti, Stefano Riccio, Sarah Colombo, Giulio Cantù, Marco A Pierotti, Silvana Pilotti.   

Abstract

Intestinal-type adenocarcinoma (ITAC) of ethmoid is a rare tumor associated with occupational exposure to wood and leather dusts. Polymorphisms in xenobiotic metabolizing enzymes play an important role in gene-environment interactions and may contribute to a high degree of variance in individual susceptibility to cancer risk. The aim of this study was to investigate by polymerase chain reaction the role of polymorphisms at CYP1A1 and GSTM1 genes in 30 ethmoid ITAC patients and 79 healthy donors. The distribution of Thr/Asn genotype at CYP1A1 codon 461 was significantly overrepresented among the patients (23.3%; P = .0422), whereas the Ile/Val genotype at CYP1A1 codon 462 was not significantly different between cases and controls (P = .76). The GSTM1 null genotype was not significantly different between cases and control (P = 1), but we observed that the combined codon 461 Thr/Asn and GSTM1 null genotype was overrepresented in the patient group (P = .0019). The results reveal that patients with CYP1A1 codon 461 polymorphism may be at high genetic risk of ITAC and that the risk increases in the presence of combined polymorphism of CYP1A1 and GSTM1 null genotype. This strongly suggests that CYP1A1 codon 461 and GSTM1 null genotype may be useful in selecting exposed individuals at risk for ethmoid ITAC.

Entities:  

Year:  2009        PMID: 19412423      PMCID: PMC2670575          DOI: 10.1593/tlo.08226

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  29 in total

1.  Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone.

Authors:  Pyotr Kisselev; Wolf-Hagen Schunck; Ivar Roots; Dieter Schwarz
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

2.  Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.

Authors:  L Licitra; S Suardi; P Bossi; L D Locati; L Mariani; P Quattrone; S Lo Vullo; M Oggionni; P Olmi; G Cantù; M A Pierotti; S Pilotti
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

3.  Craniofacial resection for tumors of the nasal cavity and paranasal sinuses--a 17-year experience.

Authors:  V J Lund; D J Howard; W I Wei; A D Cheesman
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

4.  [Malignant ethmoid-sphenoidal tumors. 130 cases. Retrospective study].

Authors:  F X Roux; J C Pages; F Nataf; B Devaux; O Laccourreye; M Menard; D Brasnu
Journal:  Neurochirurgie       Date:  1997       Impact factor: 1.553

5.  Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes.

Authors:  M Sato; T Sato; T Izumo; T Amagasa
Journal:  Oral Oncol       Date:  2000-05       Impact factor: 5.337

6.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma.

Authors:  T Katoh; N Nagata; Y Kuroda; H Itoh; A Kawahara; N Kuroki; R Ookuma; D A Bell
Journal:  Carcinogenesis       Date:  1996-09       Impact factor: 4.944

7.  Microsatellite instability analysis of sinonasal carcinomas.

Authors:  Jorge García Martínez; Jhudit Pérez-Escuredo; Fernando López; Carlos Suárez; César Alvarez-Marcos; José Luis Llorente; Mario A Hermsen
Journal:  Otolaryngol Head Neck Surg       Date:  2009-01       Impact factor: 3.497

8.  Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women.

Authors:  Chikako Kiyohara; Kenji Wakai; Haruo Mikami; Koichi Sido; Masahiko Ando; Yoshiyuki Ohno
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity.

Authors:  S Gronau; D Koenig-Greger; M Jerg; H Riechelmann
Journal:  Oral Dis       Date:  2003-03       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.